Clause 1.5 of Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002 prescribes that every physician should prescribe drugs with generic names legibly and preferably in capital letters and he/she shall ensure that there is a rational prescription and use of drug. Further, Medical Council of India has issued Circular dated 21.04.2017 vide which all the Registered Medical Practitioners have been directed to comply with the aforesaid provisions. The MCI or the appropriate State Medical Councils have been empowered to take disciplinary action against a doctor for violation of the provision of the aforesaid Regulations. As and when complaints are received against the violation of code of ethics for doctors, such complaints are referred by MCI to the concerned State Medical Councils where the doctors/medical practitioners are registered.
The Ministry of Health & Family Welfare has taken various regulatory measures to promote and ensure the quality of generic medicines. These include instructions to Licensing Authorities to grant/ renew licenses to manufacture for sale or for distribution of drugs in proper/generic names only, amendment in the Drugs and Cosmetics Rules, 1945 for making it mandatory to grant license for a drug formulation containing single active ingredient in proper name only, and inclusion of provision in the Rules, 1945 for submission of the result of bioequivalence study alongwith application for grant of manufacturing license in the case of certain drugs and also provision for joint inspection of manufacturing establishment by the Drugs Inspectors of Central Government and State Government.
(Also read: Compulsory implementation of FASTag from 15th December 2019)
Further, Bureau of Pharma PSUs of India (BPPI), the implementing agency of Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) is spreading awareness campaign about the salient features of PMBJP through various types of advertisements such as Print Media, Radio advertisement, TV advertisement, Cinema advertisements and Outdoor publicity like Hoardings, Bus Queue Shelter branding, Bus branding, auto Rikshawas wrapping. In addition to this, BPPI is also educating the public about the usages of Jan Aushadhi generic medicines through social media platforms like Facebook, Twitter, Instagram, Youtube, etc. on a daily basis.
The Minister of State (Health and Family Welfare), Sh Ashwini Kumar Choubey stated this in a written reply in the Rajya Sabha on December 03, 2019.
(Also read: Approval for land monetisation at Pragati Maidan to build a 5 star hotel)
(Also read: MCA launches Independent Director’s databank)
(Also read: MCA deactivates 19.40 lakhs Director Identification Numbers)
(Also read: 18782 cases filed under Insolvency and Bankruptcy Code)
(Also read: Election Commission of India to implement Political Parties Registration Tracking Management System)
Disclaimer: The above post includes some content used from PIB India website and executed on this website for fair use only. As this website is of educational nature, hence the content is used for education and awareness to the public.